AbbVie Seeks Accelerated FDA OK of Teliso-V in Non-Small Cell Lung Cancer
AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...
AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer
AbbVie (NYSE: ABBV) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for accelerated approval of telisotuzumab vedotin (Teliso-V) in ...
Le Lézard7m
MEDIA ADVISORY - Inn From the Cold to make special announcement about welcoming new strategic partner to expand services to vulnerable Calgarians
Inn from the Cold will be announcing a major expansion of services aimed at providing enhanced support to vulnerable Calgary families, to now include expectant mothers. Full details will be revealed ...
First novel Schizophrenia treatment in decades gains FDA approval
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
Le Lézard33m
Nucleus Security Named a Leader in the GigaOm Radar Report for Continuous Vulnerability Management (CVM)
Nucleus Security, the enterprise leader in unified vulnerability management, today announced it has been named a "Leader" in ...
Boston Omaha Has A Long Runway Ahead
Boston Omaha Corporation is a very efficient capital allocator and has potential to provide durable free cash flow moving ...
Mayo News16m
Chambers calls for IDA to purchase large-scale Mayo site to attract industry
Senator Lisa Chambers has called on the IDA (Industrial Development Authority) to purchase a large-scale site in Mayo as a ...
btimesonline48m
FDA Approves Bristol Myers Squibb’s Cobenfy, First Novel Schizophrenia Drug in 70 Years
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...